| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,322 |
5,527 |
$308K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,449 |
5,724 |
$227K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,628 |
3,422 |
$152K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,822 |
1,761 |
$134K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,611 |
1,577 |
$127K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,327 |
3,906 |
$111K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,433 |
3,149 |
$87K |
| 99429 |
|
1,319 |
1,291 |
$44K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,753 |
2,611 |
$37K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
368 |
363 |
$29K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
2,540 |
1,971 |
$21K |
| 87807 |
|
1,521 |
1,434 |
$16K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
208 |
191 |
$16K |
| 99381 |
|
240 |
217 |
$14K |
| 99215 |
Prolong outpt/office vis |
137 |
133 |
$10K |
| 92551 |
|
1,079 |
1,042 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
79 |
78 |
$7K |
| 90461 |
|
929 |
835 |
$6K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
159 |
144 |
$1K |
| 99384 |
|
12 |
12 |
$1K |
| 99382 |
|
13 |
13 |
$1K |
| 99383 |
|
18 |
12 |
$999.97 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
80 |
77 |
$883.96 |
| H0049 |
Alcohol and/or drug screening |
46 |
44 |
$727.26 |
| 17250 |
|
14 |
14 |
$684.62 |
| 96127 |
|
135 |
134 |
$295.75 |
| 85018 |
|
127 |
125 |
$240.55 |
| 85014 |
|
112 |
109 |
$208.79 |
| 90680 |
|
794 |
775 |
$58.80 |
| 99072 |
|
39 |
31 |
$12.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$2.18 |
| 90677 |
|
345 |
337 |
$1.62 |
| 90697 |
|
137 |
137 |
$0.86 |
| 90686 |
|
789 |
773 |
$0.61 |
| 91307 |
|
34 |
30 |
$0.27 |
| 90734 |
|
13 |
13 |
$0.01 |
| 90698 |
|
736 |
720 |
$0.00 |
| 90744 |
|
272 |
266 |
$0.00 |
| 36416 |
|
44 |
42 |
$0.00 |
| A7004 |
Small volume nonfiltered pneumatic nebulizer, disposable |
15 |
15 |
$0.00 |
| 90716 |
|
130 |
130 |
$0.00 |
| 90696 |
|
14 |
14 |
$0.00 |
| 90670 |
|
772 |
766 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
60 |
57 |
$0.00 |
| 99173 |
|
1,033 |
973 |
$0.00 |
| 90633 |
|
449 |
444 |
$0.00 |
| 90707 |
|
137 |
137 |
$0.00 |
| 90648 |
|
39 |
39 |
$0.00 |
| 90710 |
|
13 |
13 |
$0.00 |
| 90715 |
|
14 |
13 |
$0.00 |
| 90700 |
|
43 |
43 |
$0.00 |